TrialJournal of clinical hypertension (Greenwich, Conn.)2019

Efficacy and safety of sacubitril/valsartan compared with olmesartan in Asian patients with essential hypertension: A randomized, double-blind, 8-week study.

Yong Huo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.